According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.19. At the end of 2024 the company had a P/S ratio of 1.12.
P/S ratio history for Esperion Therapeutics from 2013 to 2024